ChromaDex Corporation logo

ChromaDex Corporation

NASDAQ:CDXC

Overview | Financials
Company Name ChromaDex Corporation
Symbol CDXC
Currency USD
Price 3.55
Market Cap 269,562,505
Dividend Yield 0%
52-week-range 1.25 - 4.65
Industry Biotechnology
Sector Healthcare
CEO Mr. Robert N. Fried
Website https://www.chromadex.com

An error occurred while fetching data.

About ChromaDex Corporation

ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to

Related Stocks

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.46 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

8.69 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

13.1 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

6.93 USD

Portage Biotech Inc. logo

Portage Biotech Inc.

PRTG

9.91 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.22 USD

Financials

Numbers are in millions USD

Numbers are in millions USD